"New study finds stroke associated with poor glycemic control in diabetics" was originally created and published by Clinical ...
Sotagliflozin (Inpefa) had a 23% risk reduction for major adverse cardiovascular events in high-risk patients with type 2 diabetes and chronic kidney disease. The dual SGLT1/2 inhibitor yielded a 32% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results